XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
CURRENT ASSETS    
Cash and cash equivalents $ 1,218,116 $ 2,786,832
Restricted cash 10,135 10,135
Accounts receivable and other, net 758,491 789,421
Other current assets 545,846 1,016,136
Total current assets 2,532,588 4,602,524
PROPERTY AND EQUIPMENT    
Equipment and office fixtures 10,859,409 11,033,536
Accumulated depreciation (10,808,027) (10,915,557)
Total property and equipment 51,382 117,979
NON-CURRENT ASSETS    
Investment in unconsolidated entity 973,159 752,667
Total non-current assets 973,159 752,667
Total assets 3,557,129 5,473,170
CURRENT LIABILITIES    
Accounts payable 3,115,212 2,772,423
Accrued expenses 10,557,654 9,804,546
Loans payable 29,605,457 29,448,988
Total current liabilities 43,278,323 42,025,957
LONG-TERM LIABILITIES    
Deferred income and revenue participation rights 3,818,750 4,643,750
Total long-term liabilities 3,818,750 4,643,750
Total liabilities 47,097,073 46,669,707
Commitments and contingencies (NOTE G)
STOCKHOLDERS' EQUITY/(DEFICIT)    
Preferred stock - $.0001 par value; 24,984,166 shares authorized; none outstanding 0 0
Common stock – $.0001 par value; 75,000,000 shares authorized; 9,222,199 and 9,222,199 issued and outstanding 922 922
Additional paid-in capital 218,016,953 217,993,953
Accumulated (deficit) (241,050,232) (239,882,346)
Total stockholders' equity/(deficit) before non-controlling interest (23,032,357) (21,887,471)
Non-controlling interest (20,507,587) (19,309,066)
Total stockholders' equity/(deficit) (43,539,944) (41,196,537)
Total liabilities and stockholders' equity/(deficit) $ 3,557,129 $ 5,473,170